Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to compare the survival of patients with metastatic
malignant melanoma treated with Taxoprexin Injection to those treated with Dacarbazine. In
addition, the response rate to each drug, response duration, time to progression and time to
treatment failure will be measured. Toxicity will be evaluated and compared between the two
groups.